China Sets Pricing Guidelines for Brain-Computer Interfaces: Invasive Procedures Priced Around RMB 6,000

Stock trading depends onGolden Qilin Analyst Report, authoritative, professional, timely, comprehensive, help you explore potential thematic opportunities!

(Source: Yicai News)

China's National Healthcare Security Administration announced on April 22 that currently, most provinces in China have established government-guided pricing for brain-computer interface-related services. The cost for invasive brain-computer interface implantation is concentrated between 6,000 to 6,600 yuan per procedure, while the fitting fee for non-invasive brain-computer interfaces is around 960 yuan, effectively stabilizing market return expectations for innovative companies.

Last month, China approved the world's first invasive brain-computer interface medical device product, which has been included in the Shanghai medical insurance medical consumables directory, accelerating the commercialization of brain-computer interfaces. The seamless integration of national regulatory approval, medical insurance pricing and payment, and clinical application effectively avoids issues for brain-computer interfaces, etc.Innovative MedicalThe Blank Dilemma of Products "Unable to Charge".

Against this backdrop, more companies are entering this track. On April 22,Lepu MedicalAt the earnings briefing, it was stated that the company's non-invasive brain-computer interface related products have already generated revenue, and the invasive multi-channel brain-computer interface product has also completed animal experiments. It has now entered the human ITT clinical research stage.

On the same day, NeuroXess, a brain-computer interface company based in Shanghai, also announced the progress of its second clinical implantation study. A high-level paraplegic patient, after receiving the implantation of a brain-computer interface device, achieved self-feeding and was able to use a brain-controlled exoskeleton to hold a pen for artistic drawing.

NeuroXess stated that the most groundbreaking significance of the latest clinical implant lies in the first-time adoption of Brain-Computer Interface-driven Functional Electrical Stimulation technology (BCI-FES), which precisely captures and analyzes motor intentions in real time through cortical electrodes, bypasses the damaged spinal cord, and accurately stimulates peripheral muscles to achieve natural and coordinated finger movements. Clinical validation shows that one month post-surgery, the patient has achieved precise voluntary grasp of the affected hand through mind control and can independently perform high-precision tasks such as writing and drawing, returning control to the patient’s own limbs.

From signal acquisition, intent decoding, command transmission to terminal execution, the full-link latency of the brain-computer interface device is less than 50 milliseconds, transforming thoughts into actions instantly. This indicator reaches the leading international level of latency control for implantable brain-computer interfaces.

Moreover, how to enable paralyzed individuals to walk again while simultaneously restoring their sense of walking has become one of the most focused research directions for researchers globally. A study published in the latest academic journal *Brain Stimulation* reports that an international research team has developed a "bidirectional brain-computer interface system." After being fully tested on a patient, the system demonstrated a control and perception accuracy rate as high as 92%, offering promising potential for future paraplegia treatment.New Hope。

Another major therapeutic direction for brain-computer interfaces is vision restoration. Industry participants, including tech billionaire Elon Musk's brain-computer interface company Neuralink, are attempting to restore sight to the blind through the implantation of brain-computer interfaces. Earlier this month, Mindtrix, a Chinese brain-computer interface company founded just a year and a half ago, announced that it had secured 150 million yuan in financing. The company is dedicated to the development of brain-computer interface products for visual reconstruction.

According to the "China Brain-Computer Interface Commercialization Prospective Report," since 2025, financing for brain-computer interface companies has entered an explosive growth phase. In 2025, there were approximately 25 financing events in the brain-computer interface sector, with a total financing amount close to 1.45 billion yuan; in the first three months of 2026, there have already been 17 financing events for brain-computer interface companies, with the total financing amount surpassing that of the entire year of 2025.

Currently, the brain-computer interface companies in the first tier in China include non-invasive technology route company BrainCo, as well as invasive brain-computer interface companies like Neuracle, StepMed, and NeuroXess. Last month, StepMed announced a 500 million yuan strategic financing round led by Alibaba, with Tencent following the investment, marking the deep involvement of internet giants in the brain-computer interface sector.

Ladder Medical revealed that in early 2026, relying on the company's independently developed surgicalRobot, successfully completed the clinical implantation of the planned 256-channel wireless high-throughput invasive brain-computer interface system, and obtained effective verification of brain-controlled interaction functions.